arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Chicago Atlantic BDC, Inc.

LIEN

$9.07 ▼ -0.10 (-1.09%) at close

20 Visible periods

16 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

Chicago Atlantic BDC, Inc. shows mixed fundamentals. Further due diligence is recommended before making investment decisions.

Market Cap $207.0M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC —

FCF / Share $1.44 ↗

Trailing P/E 33.6x

Price / Book 0.7x

FCF Yield 15.9%

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

20-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$6.06M

↓ -29.4% —

FCF / Share Free cash flow per share

$1.44

↑ +1591.2% —

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Mar 31, 2021 10-K ↗
EPS Growth YoY (%)	-28.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	12.1% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	-45.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	81.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	312.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	65.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	10.5% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	-78.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	122.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	533.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—
Net Income Growth YoY (%)	-29.4% Weak ↓ Weak Declining Year-over-year change in net income	12.1% Fair Fair Year-over-year change in net income	3.4% Caution Caution Year-over-year change in net income	N/M	N/M	N/M	24.4% Good Good Year-over-year change in net income	34.9% Excellent Excellent Year-over-year change in net income	N/M	N/M	—	N/M	472.1% Excellent Excellent Year-over-year change in net income	-97.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	1591.2% Excellent Excellent Year-over-year change in free cash flow	-186.7% Weak Weak Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	N/M	—	—	—	-190.2% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—
EPS CAGR 3Y (%)	12.4% Good ↓ Good Declining Compound annual EPS growth over 3 years	-0.9% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	—	63.0% Excellent Excellent Compound annual EPS growth over 3 years	133.1% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Mar 31, 2021 10-K ↗
FCF / Net Income (x)	5.44x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-2.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-1.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.16x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.95x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.92x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-2.03x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	-1.10x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-114.05x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.01x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Mar 31, 2021 10-K ↗
Return on Capital (%) (%)	—	—	—	—	—	—	—	-1.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-3.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	2.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	2.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	2.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15%	2.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15%	2.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	2.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	2.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	2.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	-2.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	-0.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	-1.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	7.5% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15%	-3.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	1.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	2.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	—	0.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15%	0.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15%	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Mar 31, 2021 10-K ↗
Net Debt (USD)	$-925.53K	$-3.35M	$-2.93M	$-10.46M	—	—	$-23.93M	$-30.11M	$-34.00M	$-33.16M	—	$-29.82M	$-32.90M	$-32.54M	$-35.13M	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Mar 31, 2021 10-K ↗
Basic EPS, GAAP (USD)	$0.27	$0.37	$0.36	$0.39	$0.38	$0.33	$0.66	$-0.03	$0.21	$0.08	$0.40	$0.20	$0.19	$0.38	—	$0.09	$0.03	$-0.06	—	—
Free Cash Flow per Share (USD)	$1.44	$-0.91	—	$-0.06	$0.09	$-0.32	—	—	—	$0.34	—	—	—	$-0.42	—	$0.07	$-3.89	$-0.14	—	—
Book Value per Share (USD)	$13.26	$13.33	$13.30	$13.27	$13.23	$13.19	$13.20	$13.28	$13.56	$13.60	$13.77	$14.06	$14.49	$14.29	$13.91	$13.73	$13.64	$-0.08	$13.61	—
Tangible Book Value per Share (USD)	$13.26	$13.33	$13.30	$13.27	$13.23	$13.19	$13.20	$13.28	$13.56	$13.60	$13.77	$14.06	$14.49	$14.29	$13.91	$13.73	$13.64	$-0.08	$13.61	—
Basic Weighted Avg Shares (shares)	22.82M	22.82M	—	22.82M	22.82M	22.82M	—	6.21M	6.21M	6.21M	—	6.21M	6.21M	6.21M	—	6.21M	6.21M	3.56M	—	—

🏦 How resilient is the balance sheet? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Mar 31, 2021 10-K ↗
Total Equity (USD)	$302.49M	$304.18M	$303.41M	$302.92M	$301.84M	$301.02M	$301.16M	$82.54M	$84.26M	$84.52M	$85.55M	$87.40M	$90.04M	$88.83M	$86.48M	$85.32M	$84.76M	$-507.55K	$84.55M	$-159.72K

📋 What is driving earnings? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Mar 31, 2021 10-K ↗
Net Income, GAAP (USD)	$6.06M	$8.54M	$8.25M	$8.83M	$8.58M	$7.61M	$7.97M	$-1.72M	$-260.69K	$-1.03M	$6.41M	$-2.64M	$1.21M	$2.36M	—	$559.92K	$211.74K	$85.06M	—	—
Operating Cash Flow (USD)	$32.97M	$-20.83M	$-13.77M	$-1.39M	$1.95M	$-7.26M	$-7.33M	—	—	$2.10M	$7.14M	—	—	$-2.58M	—	$437.40K	$-24.15M	$-509.11K	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 6 years · 20 quarters

Chicago Atlantic BDC, Inc.

Analytical Summary

20-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Compare LIEN with peers